It’s been a while since the last post, but I’ve been pretty busy.
Boston Globe:
1 in 10 patients gets drug error- The title basically says it all particularly with the way this study was conducted. One of the conditions for the 6 community hospitals included in the study was that they would not have their name released. The article states the importance of computerized physician order entry (CPOE) systems, which isn’t groundbreaking, but perhaps this will provide some impetus for the government to subsidize the cost of some of these systems since they aren’t economically feasible for many community hospitals or small practices.
New York Times:
China Didn’t Check Drug Supplier, Files Show- Score another for Lou Dobbs and his minions. The Baxter heparin fiasco continues with the revelation that the offending Chinese plant did not have drug certification so the national body did not inspect it. Surprisingly, Baxter hasn’t gotten killed in the stock market yet. It’s declined a little, but not the free-fall that one would expect.
Yahoo News:
Obesity boosts cancer risk, says health review- I love descriptive titles. Basically, a new study found that an increase in BMI is associated with an increased incidence of cancer.
New drug can treat alcoholism: study- Get ready for some direct-to-consumer advertising as a new study found that Revia reduces stress-induced cravings for alcohol. This could offer a solution as many people fall off the wagon when they are under stress.
